title: [Postsurgical chylous ascites: case report and literature review].
abstract: Chylous ascites derives from chyle leakage into the peritoneal cavity, either due to rupture or obstruction of abdominal lymphatic vessels. The main clinical sign is abdominal distention, while diagnosis requires the presence of triglycerides in ascitic fluid. Neoplasms are the most common cause of chylous ascites, although less common causes, such as abdominal surgery, should also be considered. The mainstay of therapy is hyperproteic diet with fat restriction and middle-chain triglycerides. Parenteral nutrition is reserved for cases in which dietary treatment fails to restore an optimal nutritional status or is contraindicated, whereas surgery is considered for patients that are deemed refractory to conservative therapy. We present a case of chylous ascites secondary to retroperitoneal lymphadenectomy.
authors.affiliation: Hospital Infanta Sofía, San Sebastián de los Reyes, Madrid, España. juaniolivar@yahoo.es
authors.forename: J
authors.initials: J
authors.lastname: Olivar Roldán
authors.forename: A
authors.initials: A
authors.lastname: Fernández Martínez
authors.forename: E
authors.initials: E
authors.lastname: Martínez Sancho
authors.forename: J
authors.initials: J
authors.lastname: Díaz Gómez
authors.forename: V
authors.initials: V
authors.lastname: Martín Borge
authors.forename: C
authors.initials: C
authors.lastname: Gómez Candela
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin; D002915:Chylous Ascites / Q000097:blood / Q000175:diagnosis / Q000178:diet therapy / Q000209:etiology* / Q000601:surgery; D002945:Cisplatin; D003131:Combined Modality Therapy; D018752:Diet, Fat-Restricted; D004044:Dietary Proteins / Q000008:administration & dosage; D019587:Dietary Supplements; D005047:Etoposide; D006801:Humans; D008197:Lymph Node Excision / Q000009:adverse effects*; D008207:Lymphatic Metastasis; D008297:Male; D009919:Orchiectomy; D019152:Paracentesis; D011183:Postoperative Complications / Q000178:diet therapy / Q000209:etiology*; D011502:Protein-Energy Malnutrition / Q000178:diet therapy / Q000209:etiology*; D018239:Seminoma / Q000188:drug therapy / Q000601:surgery; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000601:surgery; D014280:Triglycerides / Q000627:therapeutic use; D019287:Zinc Sulfate / Q000627:therapeutic use
chemical_list: D004044:Dietary Proteins; D014280:Triglycerides; D001761:Bleomycin; D005047:Etoposide; D019287:Zinc Sulfate; D002945:Cisplatin